JP2018052859A - Manufacturing method of sodium fosphenytoin hydrate and synthetic intermediate thereof - Google Patents
Manufacturing method of sodium fosphenytoin hydrate and synthetic intermediate thereof Download PDFInfo
- Publication number
- JP2018052859A JP2018052859A JP2016190904A JP2016190904A JP2018052859A JP 2018052859 A JP2018052859 A JP 2018052859A JP 2016190904 A JP2016190904 A JP 2016190904A JP 2016190904 A JP2016190904 A JP 2016190904A JP 2018052859 A JP2018052859 A JP 2018052859A
- Authority
- JP
- Japan
- Prior art keywords
- diphenyl
- imidazolidinedione
- producing
- reacting
- alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 32
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 title abstract description 5
- 229910052708 sodium Inorganic materials 0.000 title abstract description 5
- 239000011734 sodium Substances 0.000 title abstract description 5
- XWLUWCNOOVRFPX-UHFFFAOYSA-N Fosphenytoin Chemical compound O=C1N(COP(O)(=O)O)C(=O)NC1(C=1C=CC=CC=1)C1=CC=CC=C1 XWLUWCNOOVRFPX-UHFFFAOYSA-N 0.000 title abstract description 3
- 229960000693 fosphenytoin Drugs 0.000 title abstract 2
- 238000000034 method Methods 0.000 claims abstract description 37
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 33
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims abstract description 32
- CXOFVDLJLONNDW-UHFFFAOYSA-N Phenytoin Chemical compound N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 claims abstract description 26
- QQBKLRXLVRDKEB-UHFFFAOYSA-N 3-(hydroxymethyl)-5,5-diphenylimidazolidine-2,4-dione Chemical compound O=C1N(CO)C(=O)NC1(C=1C=CC=CC=1)C1=CC=CC=C1 QQBKLRXLVRDKEB-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229960002036 phenytoin Drugs 0.000 claims abstract description 16
- 238000010438 heat treatment Methods 0.000 claims abstract description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Substances [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 43
- 239000013078 crystal Substances 0.000 claims description 32
- 235000011121 sodium hydroxide Nutrition 0.000 claims description 29
- GQPXYJNXTAFDLT-UHFFFAOYSA-L disodium;(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)methyl phosphate Chemical compound [Na+].[Na+].O=C1N(COP([O-])(=O)[O-])C(=O)NC1(C=1C=CC=CC=1)C1=CC=CC=C1 GQPXYJNXTAFDLT-UHFFFAOYSA-L 0.000 claims description 25
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 16
- 238000001914 filtration Methods 0.000 claims description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 12
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- MTTPUPNRZRSDDM-UHFFFAOYSA-M potassium;dibenzyl phosphate Chemical compound [K+].C=1C=CC=CC=1COP(=O)([O-])OCC1=CC=CC=C1 MTTPUPNRZRSDDM-UHFFFAOYSA-M 0.000 claims description 10
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 9
- AKGUCIISFDTYOM-UHFFFAOYSA-N 3-(chloromethyl)-5,5-diphenylimidazolidine-2,4-dione Chemical compound O=C1N(CCl)C(=O)NC1(C=1C=CC=CC=1)C1=CC=CC=C1 AKGUCIISFDTYOM-UHFFFAOYSA-N 0.000 claims description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 7
- 239000007795 chemical reaction product Substances 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 5
- 238000002955 isolation Methods 0.000 claims description 5
- 238000002425 crystallisation Methods 0.000 claims description 4
- 230000008025 crystallization Effects 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims 1
- 238000004904 shortening Methods 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000000543 intermediate Substances 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000012044 organic layer Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 description 3
- 229940002612 prodrug Drugs 0.000 description 3
- 239000000651 prodrug Substances 0.000 description 3
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 230000001773 anti-convulsant effect Effects 0.000 description 2
- -1 chloromethyl-5,5-diphenyl-2,4-imidazolidinedione Chemical compound 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000008098 formaldehyde solution Substances 0.000 description 2
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 description 2
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- BFJBNDXKTSJDJN-UHFFFAOYSA-N 3-(bromomethyl)-5,5-diphenylimidazolidine-2,4-dione Chemical compound O=C1N(CBr)C(=O)NC1(C=1C=CC=CC=1)C1=CC=CC=C1 BFJBNDXKTSJDJN-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910000318 alkali metal phosphate Inorganic materials 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 150000004688 heptahydrates Chemical class 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Abstract
Description
本発明は、ホスフェニトインナトリウム水和物及びその合成中間体の製法に関する。 The present invention relates to a process for producing phosphenytoin sodium hydrate and synthetic intermediates thereof.
ホスフェニトインナトリウムは抗けいれん作用を持つ化合物であり、従来経口剤として用いられてきたフェニトインの水溶性プロドラッグである。フェニトインを水溶性のプロドラッグとすることで、静脈内投与時の局所刺激作用を大幅に軽減し、経口フェニトイン製剤等の投与が不可能な場合にも投与可能な製剤である。 Phosphenytoin sodium is a compound having anticonvulsant action, and is a water-soluble prodrug of phenytoin that has been conventionally used as an oral preparation. By using phenytoin as a water-soluble prodrug, the local irritation effect during intravenous administration is greatly reduced, and it can be administered even when oral phenytoin preparations cannot be administered.
特許文献１には、フェニトインを水酸化ナトリウム等の強塩基の存在下でアルデヒドまたはケトンと反応させて２−ヒドロキシアルキルフェニトインを製造する方法が記載されている。 Patent Document 1 describes a method for producing 2-hydroxyalkylphenytoin by reacting phenytoin with an aldehyde or a ketone in the presence of a strong base such as sodium hydroxide.
特許文献２には、アルカリ金属ホスフェートを、３−（クロロメチル）−または３−（ブロモメチル）−５，５−ジフェニル−２，４−イミダゾリジンジオンと処理して、所望の生成物、同様にその方法で用いられる種々の中間体を得る、リン酸２，５−ジオキソ−４，４−ジフェニル−イミダゾリジン−１−イルメチルエステルのジエステル製造の改良された方法が記載されている。 In US Pat. No. 6,057,033, an alkali metal phosphate is treated with 3- (chloromethyl)-or 3- (bromomethyl) -5,5-diphenyl-2,4-imidazolidinedione to produce the desired product, as well. An improved method for the preparation of diesters of 2,5-dioxo-4,4-diphenyl-imidazolidin-1-ylmethyl phosphate is described which yields various intermediates used in the process.
本発明は、原料費を抑え、合成中間体の収率をより高くし、工程数を減らすことにより、全製造工程にかかる時間を短縮するとともに製造コストを低減することができるホスフェニトインナトリウム水和物、及びその合成中間体の製造方法を提供することを目的とする。また本発明は、最終生成物であるホスフェニトインナトリウム水和物を製剤化した際の濁りを防止できる、ホスフェニトインナトリウム水和物、及びその合成中間体の製造方法を提供することを目的とする。 The present invention suppresses raw material costs, increases the yield of synthetic intermediates, and reduces the number of steps, thereby shortening the time required for the entire production process and reducing the production cost. It is an object to provide a method for producing a product and a synthetic intermediate thereof. Another object of the present invention is to provide a method for producing phosphenytoin sodium hydrate and a synthetic intermediate thereof that can prevent turbidity when the final product phosphenytoin sodium hydrate is formulated. .
すなわち本発明は、３−ヒドロキシメチル−５，５−ジフェニル−２，４−イミダゾリジンジオンの製造方法であって、５，５−ジフェニル−２，４−イミダゾリジンジオン（フェニトイン）、ホルムアルデヒド及びアルコールを加熱する工程を含み、かつアルカリ性物質を用いない方法である。 That is, the present invention relates to a process for producing 3-hydroxymethyl-5,5-diphenyl-2,4-imidazolidinedione, which comprises 5,5-diphenyl-2,4-imidazolidinedione (phenytoin), formaldehyde and alcohol Is a method that includes a step of heating and does not use an alkaline substance.
本発明は、３−ヒドロキシメチル−５，５−ジフェニル−２，４−イミダゾリジンジオンの製造方法であって、５，５−ジフェニル−２，４−イミダゾリジンジオン、ホルムアルデヒド及びアルコールを加熱する工程の後、得られた反応物に水を加えて結晶を析出させ、続いて析出した結晶をアルコールで洗浄した後に乾燥を行う工程を含む方法である。 The present invention relates to a method for producing 3-hydroxymethyl-5,5-diphenyl-2,4-imidazolidinedione, which comprises heating 5,5-diphenyl-2,4-imidazolidinedione, formaldehyde and alcohol. Thereafter, water is added to the obtained reaction product to precipitate crystals, and subsequently the precipitated crystals are washed with alcohol and then dried.
本発明は、５，５−ジフェニル−３−［ビス（フェニルメチル）ホスホノキシメチル］−２，４−イミダゾリジンジオンの製造方法であって、３−ヒドロキシメチル−５，５−ジフェニル−２，４−イミダゾリジンジオンの溶液に塩化チオニル等を反応させた後、生成する３−クロロメチル−５，５−ジフェニル−２，４−イミダゾリジンジオンを単離せずに溶液のままジベンジルリン酸カリウムと反応させる工程を含む方法である。 The present invention relates to a process for producing 5,5-diphenyl-3- [bis (phenylmethyl) phosphonoxymethyl] -2,4-imidazolidinedione, which comprises 3-hydroxymethyl-5,5-diphenyl-2 , 4-Imidazolidinedione is reacted with thionyl chloride and the like, and the resulting 3-chloromethyl-5,5-diphenyl-2,4-imidazolidinedione is not isolated and remains in solution with potassium dibenzylphosphate. It is a method including the process of making it react.
本発明は、５，５−ジフェニル−３−ホスホノキシメチル−２，４−イミダゾリジンジオンの製造方法であって、３−クロロメチル−５，５−ジフェニル−２，４−イミダゾリジンジオンとジベンジルリン酸カリウムを反応させ、続いて結晶化及びろ過した後、湿結晶を乾燥せずに水素と反応させる工程を含む方法である。 The present invention relates to a process for producing 5,5-diphenyl-3-phosphonoxymethyl-2,4-imidazolidinedione, comprising 3-chloromethyl-5,5-diphenyl-2,4-imidazolidinedione and This is a method comprising a step of reacting potassium dibenzyl phosphate, followed by crystallization and filtration, and then reacting the wet crystals with hydrogen without drying.
本発明は、ホスフェニトインナトリウム水和物の製造方法であって、５，５−ジフェニル−３−ホスホノキシメチル−２，４−イミダゾリジンジオンと水酸化ナトリウムとを反応させた溶液中に、酸で洗浄処理した活性炭を加えてろ別する工程を含む方法である。 The present invention relates to a method for producing phosphenytoin sodium hydrate in a solution obtained by reacting 5,5-diphenyl-3-phosphonoxymethyl-2,4-imidazolidinedione with sodium hydroxide. It is a method including a step of adding and filtering the activated carbon washed with an acid.
本発明は、ホスフェニトインナトリウム水和物の製造方法であって、５，５−ジフェニル−３−ホスホノキシメチル−２，４−イミダゾリジンジオンと水酸化ナトリウムとを反応させた溶液をろ別した後、ろ液にアセトンを加えて攪拌して結晶を析出させ、析出した結晶を室温及び常圧下で乾燥する工程を含む方法である。 The present invention relates to a method for producing phosphenytoin sodium hydrate, which is obtained by filtering a solution obtained by reacting 5,5-diphenyl-3-phosphonoxymethyl-2,4-imidazolidinedione and sodium hydroxide. Then, acetone is added to the filtrate and stirred to precipitate crystals, and the precipitated crystals are dried at room temperature and normal pressure.
本発明は、ホスフェニトインナトリウム水和物の製造方法であって、５，５−ジフェニル−２，４−イミダゾリジンジオン（フェニトイン）、ホルムアルデヒド及びアルコールを加熱する工程を含み、かつアルカリ性物質を用いずに３−ヒドロキシメチル−５，５−ジフェニル−２，４−イミダゾリジンジオンを製造する工程を含む方法である。 The present invention relates to a method for producing phosphenytoin sodium hydrate, comprising a step of heating 5,5-diphenyl-2,4-imidazolidinedione (phenytoin), formaldehyde and alcohol, and without using an alkaline substance. And 3-hydroxymethyl-5,5-diphenyl-2,4-imidazolidinedione.
本発明は、ホスフェニトインナトリウム水和物の製造方法であって、５，５−ジフェニル−２，４−イミダゾリジンジオン（フェニトイン）、ホルムアルデヒド及びアルコールを加熱する工程の後、この工程の反応物に水を加えて結晶を析出させ、続いて析出した結晶をアルコールで洗浄した後に乾燥を行う工程を含む方法である。 The present invention relates to a method for producing phosphenytoin sodium hydrate, which comprises heating a 5,5-diphenyl-2,4-imidazolidinedione (phenytoin), formaldehyde, and alcohol, and then adding the reaction product in this step. It is a method including a step of adding water to precipitate crystals, and subsequently drying the precipitated crystals after washing with alcohol.
本発明は、ホスフェニトインナトリウム水和物の製造方法であって、３−ヒドロキシメチル−５，５−ジフェニル−２，４−イミダゾリジンジオンの溶液に塩化チオニル等を反応させた後、生成する３−クロロメチル−５，５−ジフェニル−２，４−イミダゾリジンジオンを単離せずに溶液のままジベンジルリン酸カリウムと反応させる工程を含む方法である。 The present invention relates to a method for producing phosphenytoin sodium hydrate, which is produced after reacting a solution of 3-hydroxymethyl-5,5-diphenyl-2,4-imidazolidinedione with thionyl chloride or the like 3 -A method comprising a step of reacting chloromethyl-5,5-diphenyl-2,4-imidazolidinedione with potassium dibenzyl phosphate in a solution without isolation.
本発明は、ホスフェニトインナトリウム水和物の製造方法であって、３−クロロメチル−５，５−ジフェニル−２，４−イミダゾリジンジオンとジベンジルリン酸カリウムを反応させ、続いて結晶化及びろ過した後、湿結晶を乾燥せずに水素と反応させる工程を含む方法である。 The present invention is a method for producing phosphenytoin sodium hydrate, which comprises reacting 3-chloromethyl-5,5-diphenyl-2,4-imidazolidinedione with potassium dibenzyl phosphate, followed by crystallization and filtration. Then, it is a method including the process of making it react with hydrogen, without drying a wet crystal.
本発明により、原料費を抑え、合成中間体の収率をより高くし、工程数を減らすことにより、全製造工程にかかる時間を短縮するとともに製造コストを低減することができるホスフェニトインナトリウム水和物、及びその合成中間体の製造方法、並びに、最終生成物であるホスフェニトインナトリウム水和物を製剤化した際の濁りを防止できる、ホスフェニトインナトリウム水和物、及びその合成中間体の製造方法を提供することが可能となる。 According to the present invention, phosphenytoin sodium hydration can reduce the manufacturing cost while reducing the time required for the entire manufacturing process by reducing raw material costs, increasing the yield of synthetic intermediates, and reducing the number of processes. , And a synthetic intermediate production method thereof, and phosphenytoin sodium hydrate capable of preventing turbidity when the final product phosphenytoin sodium hydrate is formulated, and a synthetic intermediate production method thereof Can be provided.
本発明の製造方法を、合成スキームを参照しながら説明する。 The production method of the present invention will be described with reference to a synthesis scheme.
スキーム１：３−ヒドロキシメチル−５，５−ジフェニル−２，４−イミダゾリジンジオン（３−ヒドロキシメチルフェニトイン）の製造
５，５−ジフェニル−２，４−イミダゾリジンジオン（フェニトイン）とホルムアルデヒド水溶液を、エタノールなどのアルコールと共に加熱し、水酸化ナトリウムや炭酸カリウムなどのアルカリ性物質は用いずに３−ヒドロキシメチル−５，５−ジフェニル−２，４−イミダゾリジンジオンを製造する。フェニトインとホルムアルデヒド水溶液のみでもこの反応は進み、アルカリ性物質を用いる必要がないため製造コストを抑えることができる。 5,5-diphenyl-2,4-imidazolidinedione (phenytoin) and an aqueous formaldehyde solution are heated with an alcohol such as ethanol, and without using an alkaline substance such as sodium hydroxide or potassium carbonate, 3-hydroxymethyl-5, 5-diphenyl-2,4-imidazolidinedione is produced. This reaction proceeds even with phenytoin and formaldehyde aqueous solution alone, and it is not necessary to use an alkaline substance, so that the production cost can be reduced.
また、スキーム１においてホルムアルデヒド水溶液及びアルコールを加熱する工程の後、得られた反応物に水を加えて結晶を析出させ、続いて析出した結晶をアルコールで洗浄した後に乾燥を行い、３−ヒドロキシメチル−５，５−ジフェニル−２，４−イミダゾリジンジオンを製造することができる。結晶をアルコールで洗浄した後に乾燥を行うことで、副産物としてのフェニトインを例えば３％未満に抑えることができ、目的とする合成中間体の収率、ひいては最終生成物であるホスフェニトインナトリウム水和物の収率をより上げることができる。
ここで用いるアルコールとしては、メタノール、エタノール、ｎ−プロパノール、またはイソプロパノール等の低級アルコールを用いることができる。これらアルコールの中でも、エタノールを用いることが好ましい。
Further, after the step of heating the aqueous formaldehyde solution and alcohol in Scheme 1, water is added to the obtained reaction product to precipitate crystals. Subsequently, the precipitated crystals are washed with alcohol and then dried, and 3-hydroxymethyl -5,5-Diphenyl-2,4-imidazolidinedione can be produced. By washing the crystals with alcohol and then drying, the phenytoin as a by-product can be suppressed to less than 3%, for example, and the yield of the target synthetic intermediate, and thus the final product, phosphenytoin sodium hydrate The yield of can be further increased.
As alcohol used here, lower alcohols, such as methanol, ethanol, n-propanol, or isopropanol, can be used. Among these alcohols, it is preferable to use ethanol.
スキーム２：５，５−ジフェニル−３−［ビス（フェニルメチル）ホスホノキシメチル］−２，４−イミダゾリジンジオンの製造
スキーム１で得られた３−ヒドロキシメチル−５，５−ジフェニル−２，４−イミダゾリジンジオンの溶液に、塩化チオニル等を反応させる。
ここで生成する３−クロロメチル−５，５−ジフェニル−２，４−イミダゾリジンジオンは単離せずに、溶液のまま次の工程（２）に進むことができる。単離工程を省いて次の工程に進めるため、製造工程を１〜２日短縮することができる。
The solution of 3-hydroxymethyl-5,5-diphenyl-2,4-imidazolidinedione obtained in Scheme 1 is reacted with thionyl chloride and the like.
The 3-chloromethyl-5,5-diphenyl-2,4-imidazolidinedione produced here can proceed to the next step (2) as it is without isolation. Since the isolation process is omitted and the process proceeds to the next process, the manufacturing process can be shortened by 1 to 2 days.
続いて、反応混合物を冷却し有機層を分離して、乾燥、濃縮し、溶媒を加えてジベンジルリン酸カリウム、炭酸カリウム、ヨウ化カリウムと反応させる。反応混合物を冷却し、酢酸エチルを加えて水で洗浄した後活性炭を加えて攪拌、ろ過し、有機層から５，５−ジフェニル−３−［ビス（フェニルメチル）ホスホノキシメチル］−２，４−イミダゾリジンジオンの湿結晶を得ることができる。 Subsequently, the reaction mixture is cooled and the organic layer is separated, dried and concentrated, and a solvent is added to react with potassium dibenzyl phosphate, potassium carbonate and potassium iodide. The reaction mixture was cooled, ethyl acetate was added and washed with water, activated carbon was added, stirred and filtered, and 5,5-diphenyl-3- [bis (phenylmethyl) phosphonoxymethyl] -2, A wet crystal of 4-imidazolidinedione can be obtained.
スキーム３：
スキーム２で得られた５，５−ジフェニル−３−［ビス（フェニルメチル）ホスホノキシメチル］−２，４−イミダゾリジンジオンの湿結晶をそのまま、水素と反応させる。詳しくは、得られた湿結晶をメタノール及びパラジウム炭素を混合しながら水素ガスを通気して反応させる。反応終了後、減圧濃縮し、濃縮物にアセトンを加えて加熱し、次いで冷却してトルエンを加え、１０℃以下で撹拌し、析出した結晶をろ別してトルエンで洗浄、減圧乾燥して５，５−ジフェニル−３−ホスホノキシメチル−２，４−イミダゾリジンジオンを得ることができる。５，５−ジフェニル−３−［ビス（フェニルメチル）ホスホノキシメチル］−２，４−イミダゾリジンジオンの湿結晶をそのまま工程に用いても、水素との反応は進み、その結果製造工程を約１日短縮することができる。 The 5,5-diphenyl-3- [bis (phenylmethyl) phosphonoxymethyl] -2,4-imidazolidinedione wet crystal obtained in Scheme 2 is reacted with hydrogen as it is. Specifically, the obtained wet crystal is reacted by aeration of hydrogen gas while mixing methanol and palladium carbon. After completion of the reaction, the reaction mixture was concentrated under reduced pressure. Acetone was added to the concentrate and heated, then cooled, toluene was added, and the mixture was stirred at 10 ° C. or lower. The precipitated crystals were separated by filtration, washed with toluene, and dried under reduced pressure. -Diphenyl-3-phosphonoxymethyl-2,4-imidazolidinedione can be obtained. Even if wet crystals of 5,5-diphenyl-3- [bis (phenylmethyl) phosphonoxymethyl] -2,4-imidazolidinedione are used as they are in the process, the reaction with hydrogen proceeds, and as a result, the production process It can be shortened by about 1 day.
スキーム４：
スキーム３で得られた５，５−ジフェニル−３−ホスホノキシメチル−２，４−イミダゾリジンジオンに、水及びエタノールを混合して撹拌し、ｐＨをアルカリに調整して溶解する。続いて、酸で洗浄処理した活性炭（例えば、Ｃａｂｏｔ Ｎｏｒｉｔ Ｎｅｄｅｒｌａｎｄ社製ＮＯＲＩＴ(登録商標) ＳＸ ＰＬＵＳ）を加えて撹拌してろ別し、ろ液にアセトンを加えて冷却、撹拌し、析出した結晶をろ別し湿結晶を得たのち、これを乾燥してホスフェニトインナトリウム水和物を得ることができる。酸で洗浄処理した活性炭を用いることで、ホスフェニトインナトリウム水溶液として製剤化する際に、濁りの無い製剤を得ることができる。 The 5,5-diphenyl-3-phosphonoxymethyl-2,4-imidazolidinedione obtained in Scheme 3 is mixed with water and ethanol and stirred, and the pH is adjusted to alkali and dissolved. Subsequently, activated carbon washed with acid (for example, NORIT (registered trademark) SX PLUS manufactured by Cabot Norit Nederland) is added and stirred, and filtered. Acetone is added to the filtrate, and the mixture is cooled and stirred. After filtering and obtaining wet crystals, this can be dried to obtain sodium phosphenytoin hydrate. By using activated carbon that has been washed with an acid, a formulation without turbidity can be obtained when it is formulated as a sodium phosphenytoin aqueous solution.
（実施例１）
３−ヒドロキシメチル−５，５−ジフェニル−２，４−イミダゾリジンジオンの製造
フェニトイン３０ｋｇ、３７％ホルムアルデヒド１９ｋｇ及びエタノール６０Ｌを約５０℃に加熱して数時間撹拌した。次いで反応物を冷却し、水を６０Ｌ加えて撹拌し、析出した結晶をろ別してエタノール６０Ｌで洗浄した。得られた湿ケーキを減圧乾燥し、３−ヒドロキシメチル−５，５−ジフェニル−２，４−イミダゾリジンジオン（３０ｋｇ、収率１００ｗｔ％）を得た。
Example 1
Production of 3-hydroxymethyl-5,5-diphenyl-2,4-imidazolidinedione 30 kg of phenytoin, 19 kg of 37% formaldehyde and 60 L of ethanol were heated to about 50 ° C. and stirred for several hours. Next, the reaction product was cooled, 60 L of water was added and stirred, and the precipitated crystals were separated by filtration and washed with 60 L of ethanol. The obtained wet cake was dried under reduced pressure to obtain 3-hydroxymethyl-5,5-diphenyl-2,4-imidazolidinedione (30 kg, yield 100 wt%).
（実施例２）
５，５−ジフェニル−３−［ビス（フェニルメチル）ホスホノキシメチル］−２，４−イミダゾリジンジオンの製造
３−ヒドロキシメチル−５，５−ジフェニル−２，４−イミダゾリジンジオン３０ｋｇ、ジメチルホルムアミド０．６Ｌ、塩化チオニル１３．５ｋｇ及び酢酸エチル１５０Ｌを約５０℃に加熱して３０分以上撹拌した。反応混合物を冷却し、酢酸エチル６０Ｌ及び水１５０Ｌを加えて混合して有機層を分離した。分離した有機層に無水硫酸ナトリウム３ｋｇを加えて乾燥し、容量が約６０Ｌになるまで減圧濃縮した。
濃縮した溶液に、酢酸エチル３０Ｌを加え、さらにジベンジルリン酸カリウム３０ｋｇ、炭酸カリウム０．７ｋｇ及びヨウ化カリウム０．３５ｋｇを加えた後、約７０℃に加熱して数時間撹拌した。反応混合物を冷却し、酢酸エチル６０Ｌを加えて水で洗浄した後、活性炭１．３ｋｇを加えて撹拌し、ろ別した。有機層を減圧濃縮し、トルエン３００Ｌを加えて加熱撹拌した後、冷却した。析出した結晶をろ別してトルエンで洗浄し、５，５−ジフェニル−３−［ビス（フェニルメチル）ホスホノキシメチル］−２，４−イミダゾリジンジオンの湿結晶を得た。
(Example 2)
Preparation of 5,5-diphenyl-3- [bis (phenylmethyl) phosphonoxymethyl] -2,4-imidazolidinedione 3-hydroxymethyl-5,5-diphenyl-2,4-imidazolidinedione 30 kg, dimethyl 0.6 L of formamide, 13.5 kg of thionyl chloride and 150 L of ethyl acetate were heated to about 50 ° C. and stirred for 30 minutes or more. The reaction mixture was cooled, 60 L of ethyl acetate and 150 L of water were added and mixed to separate the organic layer. The separated organic layer was dried by adding 3 kg of anhydrous sodium sulfate, and concentrated under reduced pressure until the volume reached about 60 L.
30 L of ethyl acetate was added to the concentrated solution, and 30 kg of potassium dibenzyl phosphate, 0.7 kg of potassium carbonate and 0.35 kg of potassium iodide were added, and the mixture was heated to about 70 ° C. and stirred for several hours. The reaction mixture was cooled, 60 L of ethyl acetate was added and washed with water, then 1.3 kg of activated carbon was added, stirred and filtered. The organic layer was concentrated under reduced pressure, 300 L of toluene was added and the mixture was heated and stirred, and then cooled. The precipitated crystals were collected by filtration and washed with toluene to obtain wet crystals of 5,5-diphenyl-3- [bis (phenylmethyl) phosphonoxymethyl] -2,4-imidazolidinedione.
（実施例３）
５，５−ジフェニル−３−ホスホノキシメチル−２，４−イミダゾリジンジオンの製造
実施例２で得られた５，５−ジフェニル−３−［ビス（フェニルメチル）ホスホノキシメチル］−２，４−イミダゾリジンジオンの湿結晶（得られた状態のままのもの）、メタノール１５０Ｌ及び５％パラジウム炭素１．５ｋｇを混合しながら水素ガスを通気して反応させた。反応終了後、減圧濃縮し、濃縮物にアセトン６０Ｌを加えて６０℃以上で３０分以上加熱した。次いで冷却してトルエン３０Ｌを加え、１０℃以下で一夜撹拌した。析出した結晶をろ別してトルエンで洗浄し、減圧乾燥を一夜行って５，５−ジフェニル−３−ホスホノキシメチル−２，４−イミダゾリジンジオン（２０ｋｇ、収率６７ｗｔ％（３−ヒドロキシメチル−５，５−ジフェニル−２，４−イミダゾリジンジオン基準））を得た。
(Example 3)
Preparation of 5,5-diphenyl-3-phosphonoxymethyl-2,4-imidazolidinedione 5,5-diphenyl-3- [bis (phenylmethyl) phosphonoxymethyl] -2 obtained in Example 2 , 4-imidazolidinedione wet crystals (as obtained), 150 L of methanol and 1.5 kg of 5% palladium carbon were mixed and reacted with hydrogen gas aerated. After completion of the reaction, the mixture was concentrated under reduced pressure, 60 L of acetone was added to the concentrate, and the mixture was heated at 60 ° C. or higher for 30 minutes or longer. Next, the mixture was cooled, 30 L of toluene was added, and the mixture was stirred overnight at 10 ° C. or lower. The precipitated crystals were separated by filtration, washed with toluene, and dried under reduced pressure overnight to give 5,5-diphenyl-3-phosphonoxymethyl-2,4-imidazolidinedione (20 kg, yield 67 wt% (3-hydroxymethyl- 5,5-diphenyl-2,4-imidazolidinedione standard)) was obtained.
（実施例４）
ホスフェニトインナトリウム水和物の製造
５，５−ジフェニル−３−ホスホノキシメチル−２，４−イミダゾリジンジオン２０ｋｇ、水３５Ｌ及びエタノール５０Ｌを混合して撹拌しながら約４％の水酸化ナトリウム水溶液を加えてｐＨ８．２〜９．３に調節した。次いで酸で洗浄処理した活性炭（Ｃａｂｏｔ Ｎｏｒｉｔ Ｎｅｄｅｒｌａｎｄ社製ＮＯＲＩＴ(登録商標) ＳＸ ＰＬＵＳ）０．９ｋｇを加えて撹拌してろ別し、ろ液にアセトン３００Ｌを加え冷却しながら３０分間撹拌した。析出した結晶をろ別し湿結晶を室温、常圧で一夜乾燥してホスフェニトインナトリウム水和物（２３ｋｇ、収率１１５ｗｔ％）を得た。
Example 4
Preparation of sodium phosphenytoin hydrate 20 kg of 5,5-diphenyl-3-phosphonoxymethyl-2,4-imidazolidinedione, 35 L of water and 50 L of ethanol are mixed and stirred with about 4% aqueous sodium hydroxide solution Was added to adjust the pH to 8.2 to 9.3. Next, 0.9 kg of activated carbon washed with acid (NORIT (registered trademark) SX PLUS manufactured by Cabot Norit Nederland) was added and stirred for filtration, and 300 L of acetone was added to the filtrate and stirred for 30 minutes while cooling. The precipitated crystals were separated by filtration and the wet crystals were dried overnight at room temperature and normal pressure to obtain phosphenytoin sodium hydrate (23 kg, yield 115 wt%).
本発明により得られたホスフェニトインナトリウム水和物（例えば、７水和物）を水溶液とすることにより、フェニトインのプロドラッグであるホスフェニトインナトリウム水和物を注射により投与し、抗けいれん剤として使用することができる。 Phosphenytoin sodium hydrate (eg, heptahydrate) obtained by the present invention is made into an aqueous solution, and phosphenytoin sodium hydrate, a prodrug of phenytoin, is administered by injection and used as an anticonvulsant. can do.
Claims (11)
５，５−ジフェニル−２，４−イミダゾリジンジオン（フェニトイン）、ホルムアルデヒド及びアルコールを加熱する工程を含み、かつアルカリ性物質を用いない方法。 A process for producing 3-hydroxymethyl-5,5-diphenyl-2,4-imidazolidinedione, comprising:
A method comprising heating 5,5-diphenyl-2,4-imidazolidinedione (phenytoin), formaldehyde and alcohol, and using no alkaline substance.
５，５−ジフェニル−２，４−イミダゾリジンジオン、ホルムアルデヒド及びアルコールを加熱する工程の後、
得られた反応物に水を加えて結晶を析出させ、続いて析出した結晶をアルコールで洗浄した後に乾燥を行う工程を含む方法。 A process for producing 3-hydroxymethyl-5,5-diphenyl-2,4-imidazolidinedione, comprising:
After the step of heating 5,5-diphenyl-2,4-imidazolidinedione, formaldehyde and alcohol,
A method comprising a step of adding water to the obtained reaction product to precipitate crystals, and subsequently drying the precipitated crystals after washing with alcohol.
３−ヒドロキシメチル−５，５−ジフェニル−２，４−イミダゾリジンジオンの溶液に塩化チオニルを反応させた後、生成する３−クロロメチル−５，５−ジフェニル−２，４−イミダゾリジンジオンを単離せずに溶液のままジベンジルリン酸カリウムと反応させる工程を含む方法。 A process for producing 5,5-diphenyl-3- [bis (phenylmethyl) phosphonoxymethyl] -2,4-imidazolidinedione,
After reacting thionyl chloride with a solution of 3-hydroxymethyl-5,5-diphenyl-2,4-imidazolidinedione, the resulting 3-chloromethyl-5,5-diphenyl-2,4-imidazolidinedione A method comprising a step of reacting with potassium dibenzyl phosphate as a solution without isolation.
３−クロロメチル−５，５−ジフェニル−２，４−イミダゾリジンジオンとジベンジルリン酸カリウムを反応させ、続いて結晶化及びろ過した後、湿結晶を乾燥せずに水素と反応させる工程を含む方法。 A process for producing 5,5-diphenyl-3-phosphonoxymethyl-2,4-imidazolidinedione, comprising:
A method comprising reacting 3-chloromethyl-5,5-diphenyl-2,4-imidazolidinedione with potassium dibenzyl phosphate, followed by crystallization and filtration, and then reacting the wet crystals with hydrogen without drying. .
５，５−ジフェニル−３−ホスホノキシメチル−２，４−イミダゾリジンジオンと水酸化ナトリウムとを反応させた溶液中に、酸で洗浄処理した活性炭を加えてろ別する工程を含む方法。 A method for producing phosphenytoin sodium hydrate comprising:
A method comprising a step of adding an activated carbon washed with an acid to a solution obtained by reacting 5,5-diphenyl-3-phosphonoxymethyl-2,4-imidazolidinedione and sodium hydroxide, followed by filtration.
５，５−ジフェニル−３−ホスホノキシメチル−２，４−イミダゾリジンジオンと水酸化ナトリウムとを反応させた溶液をろ別した後、ろ液にアセトンを加えて攪拌して結晶を析出させ、析出した結晶を室温及び常圧下で乾燥する工程を含む方法。 A method for producing phosphenytoin sodium hydrate comprising:
After filtering out a solution obtained by reacting 5,5-diphenyl-3-phosphonoxymethyl-2,4-imidazolidinedione and sodium hydroxide, acetone was added to the filtrate and stirred to precipitate crystals. And a method comprising drying the precipitated crystals at room temperature and normal pressure.
５，５−ジフェニル−２，４−イミダゾリジンジオン（フェニトイン）、ホルムアルデヒド及びアルコールを加熱する工程を含み、かつアルカリ性物質を用いずに３−ヒドロキシメチル−５，５−ジフェニル−２，４−イミダゾリジンジオンを製造する工程を含む方法。 A method for producing phosphenytoin sodium hydrate comprising:
A process comprising heating 5,5-diphenyl-2,4-imidazolidinedione (phenytoin), formaldehyde and alcohol, and without using an alkaline substance, 3-hydroxymethyl-5,5-diphenyl-2,4-imidazole A method comprising the step of producing lysinedione.
５，５−ジフェニル−２，４−イミダゾリジンジオン（フェニトイン）、ホルムアルデヒド及びアルコールを加熱する工程の後、
この工程の反応物に水を加えて結晶を析出させ、続いて析出した結晶をアルコールで洗浄した後に乾燥を行う工程を含む方法。 A method for producing phosphenytoin sodium hydrate comprising:
After the step of heating 5,5-diphenyl-2,4-imidazolidinedione (phenytoin), formaldehyde and alcohol,
A method comprising a step of adding water to the reaction product in this step to precipitate crystals, and subsequently drying the precipitated crystals after washing with alcohol.
３−ヒドロキシメチル−５，５−ジフェニル−２，４−イミダゾリジンジオンの溶液に塩化チオニル等を反応させた後、生成する３−クロロメチル−５，５−ジフェニル−２，４−イミダゾリジンジオンを単離せずに溶液のままジベンジルリン酸カリウムと反応させる工程を含む方法。 A method for producing phosphenytoin sodium hydrate comprising:
3-chloromethyl-5,5-diphenyl-2,4-imidazolidinedione produced after reacting thionyl chloride and the like with a solution of 3-hydroxymethyl-5,5-diphenyl-2,4-imidazolidinedione And reacting with potassium dibenzyl phosphate in solution without isolation.
３−クロロメチル−５，５−ジフェニル−２，４−イミダゾリジンジオンとジベンジルリン酸カリウムを反応させ、続いて結晶化及びろ過した後、湿結晶を乾燥せずに水素と反応させる工程を含む方法。 A method for producing phosphenytoin sodium hydrate comprising:
A method comprising reacting 3-chloromethyl-5,5-diphenyl-2,4-imidazolidinedione with potassium dibenzyl phosphate, followed by crystallization and filtration, and then reacting the wet crystals with hydrogen without drying. .
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016190904A JP6861430B2 (en) | 2016-09-29 | 2016-09-29 | Method for producing sodium phosphenytoin hydrate and its synthetic intermediate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016190904A JP6861430B2 (en) | 2016-09-29 | 2016-09-29 | Method for producing sodium phosphenytoin hydrate and its synthetic intermediate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018052859A true JP2018052859A (en) | 2018-04-05 |
| JP6861430B2 JP6861430B2 (en) | 2021-04-21 |
Family
ID=61833923
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016190904A Active JP6861430B2 (en) | 2016-09-29 | 2016-09-29 | Method for producing sodium phosphenytoin hydrate and its synthetic intermediate |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6861430B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113234547A (en) * | 2021-05-26 | 2021-08-10 | 德州竹洋洗涤科技有限公司 | Efficient detergent for fabric |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5852274A (en) * | 1981-08-26 | 1983-03-28 | 太平洋化学工業株式会社 | 5-(4-hydroxyphenyl)hydantoin derivative and manufacture |
| JP2000509071A (en) * | 1996-04-30 | 2000-07-18 | ワーナー―ランバート・コンパニー | An improved method for the synthesis of diesters of 2,5-dioxo-4,4-diphenyl-imidazolidin-1-ylmethyl phosphate |
| CN101311167A (en) * | 2007-05-25 | 2008-11-26 | 天津药物研究院 | 1-phenyl glyoxaline alkane -2,4-dione derivates and uses thereof |
-
2016
- 2016-09-29 JP JP2016190904A patent/JP6861430B2/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5852274A (en) * | 1981-08-26 | 1983-03-28 | 太平洋化学工業株式会社 | 5-(4-hydroxyphenyl)hydantoin derivative and manufacture |
| JP2000509071A (en) * | 1996-04-30 | 2000-07-18 | ワーナー―ランバート・コンパニー | An improved method for the synthesis of diesters of 2,5-dioxo-4,4-diphenyl-imidazolidin-1-ylmethyl phosphate |
| CN101311167A (en) * | 2007-05-25 | 2008-11-26 | 天津药物研究院 | 1-phenyl glyoxaline alkane -2,4-dione derivates and uses thereof |
Non-Patent Citations (1)
| Title |
|---|
| Ｃ．Ｇ．ＷＥＲＭＵＴＨ編, 「最新 創薬化学 下巻」, vol. 第３４７〜３６５頁, JPN6014029314, 1999, ISSN: 0004344986 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113234547A (en) * | 2021-05-26 | 2021-08-10 | 德州竹洋洗涤科技有限公司 | Efficient detergent for fabric |
Also Published As
| Publication number | Publication date |
|---|---|
| JP6861430B2 (en) | 2021-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103012305A (en) | Method for preparing fosaprepitant intermediate | |
| JP6861430B2 (en) | Method for producing sodium phosphenytoin hydrate and its synthetic intermediate | |
| DE3532344A1 (en) | METHOD FOR PRODUCING N-PHOSPHONOMETHYLGLYCINE | |
| JPH02174789A (en) | Preparation of riboflavin-4', 5'-cyclophosphoric ester chloride and riboflavin-5'-phosphate(5'-fmn) or sodium salt thereof | |
| CN107879979B (en) | Preparation method of dexmedetomidine | |
| CN107188888A (en) | A kind of methanesulfonic acid for preparing steps the auspicious method for Buddhist nun | |
| JPS6024781B2 (en) | Method for producing cis-2-hydroxy-2-phenyl-r-1-cyclohexanecarboxylic acid | |
| KR20180105450A (en) | A Method of preparing Fimarsartan choline salt and hydrate thereof | |
| CN106542961B (en) | A kind of synthetic method of racecadotril intermediate | |
| CN105949196A (en) | Preparation method of MER/FLT3 dual-inhibitor intermediate | |
| CN106866560B (en) | Lesinurad synthesis method | |
| KR100829894B1 (en) | Preparing method of dimecrotic acid and magnesium salt thereof | |
| KR20140140398A (en) | A synthetic method of high purity mirtazapine | |
| CN104230909B (en) | A kind of preparation method of Azilsartan | |
| US4247693A (en) | Process for preparing 2,4,5,6-tetraaminopyrimidine sulfate | |
| CN108558676B (en) | Preparation method of N, N-dibenzylethylenediamine diacetate | |
| CN112778212B (en) | Synthesis method of cropanisin intermediate 2-aminopyrimidine-5-methyl carboxylate | |
| US862675A (en) | Orthodioxyphenylethanolamin. | |
| KR20180123851A (en) | Novel crystal form of lenalidomide and preparation of the same | |
| JP6336166B2 (en) | Novel intermediate of imidafenacin, method for producing the same, and method for producing imidafenacin using the same | |
| CN106432095B (en) | The preparation of -3 (2H) -one of pimobendan key intermediate 6- (3,4- diamino-phenyl) -5- methyl -4,5- dihydrogen dazin | |
| CN106854182B (en) | Preparation method of 2, 5-dichloro-N- (2- (isopropylsulfonyl) phenyl) pyrimidine-4-amine | |
| CN1800169B (en) | Pemetrexed disodium key intermediate and its synthesis method, and method for synthesizing pemetrexed disodium from the said intermediate | |
| JP6219516B2 (en) | Method for producing 2-amino-6-methylnicotinic acid | |
| JPH10310568A (en) | N-alkoxycarbonyl-l-asparagine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190918 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20200730 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200915 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20201030 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210114 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210316 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210323 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6861430 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |